EICHOR
● Active Not Recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Condition: Crohn's Disease · Sponsor: Janssen-Cilag Ltd.
About this study
The purpose of this study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic Resonance Index of Activity (MaRIA) based on a scan at Week 48.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (84)
| Center for Colitis and Crohns Disease University of California | San Francisco, California, United States | — |
| The University of Chicago Medical Center (UCMC) | Chicago, Illinois, United States | — |
| Washington University School Of Medicine | St Louis, Missouri, United States | — |
| Medical University of South Carolina | Charleston, South Carolina, United States | — |
| The Queen Elizabeth Hospital | Adelaide, Australia | — |
| Concord Repatriation General Hospital | Concord, Australia | — |
| Northern Hospital | Melbourne, Australia | — |
| Fiona Stanley Hospital | Murdoch, Australia | — |
| Mater Hospital Brisbane | South Brisbane, Australia | — |
| AZ Maria Middelares | Ghent, Belgium | — |
| CHU de Liege | Liège, Belgium | — |
| Vitaz | Sint-Niklaas, Belgium | — |
+ 72 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06408935